Tumor volume growth as surrogate endpoint in IDH-mt glioma — Response Correspondence

  

Authors:	Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Malani, R.; Panageas, K. S.; Mellinghoff, I. K.; Bale, T. A.; Young, R. J.
Title:	Tumor volume growth as surrogate endpoint in IDH-mt glioma — Response
Keywords:	genetics; mutation; postoperative period; molecular genetics; brain tumor; glioma; brain neoplasms; letter; biomarkers; biological marker; tumor volume; pathology; confidence interval; statistical significance; tumor burden; tumor growth; mutant; chromosome 1p; isocitrate dehydrogenase; humans; human; idh mutated glioma
Journal Title:	Clinical Cancer Research
Volume:	30
Issue:	3
ISSN:	1078-0432
Publisher:	American Association for Cancer Research
Date Published:	2024-02-01
Start Page:	639
Language:	English
DOI:	10.1158/1078-0432.Ccr-23-3603
PUBMED:	38298142
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85183797124&doi=10.1158%2f1078-0432.CCR-23-3603&partnerID=40&md5=9fd67d1bc5f30269788bf0a518d33286
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/213839